Lv21
110 积分 2025-04-21 加入
Cefiderocol: the Trojan horse has arrived but will Troy fall?
52分钟前
待确认
Cefiderocol: Clinical application and emergence of resistance
3天前
已完结
Realizing the promise of CAR-T cell therapies for autoimmune diseases
4天前
已完结
Shifts in pharma’s therapeutic area focus
4天前
已完结
Designing GPCR-targeted miniproteins
4天前
已完结
Evolution of the psoriasis therapy landscape
4天前
已完结
Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial
11天前
已完结
Treatment of chronic obstructive pulmonary disease: current pipeline and new opportunities
21天前
已完结
Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial
28天前
已完结
Tissue-resident memory T cells in diseases and therapeutic strategies
1个月前
已完结
皖公网安备34019202002308
